| human | Q5 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 198008082 |
| P496 | ORCID iD | 0000-0001-5550-4159 |
| P214 | VIAF ID | 290636766 |
| P10832 | WorldCat Entities ID | E39PBJppDgvctfqHYp4xJvqqQq |
| P108 | employer | Institute of Cancer Research Sutton | Q102869483 |
| P735 | given name | Anthony | Q12241622 |
| Anthony | Q12241622 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q59355837 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk |
| Q30473239 | A case-control study of risk of leukaemia in relation to mobile phone use. |
| Q33685010 | A case-control study of the aetiology of cryptorchidism |
| Q33997176 | A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis |
| Q35977876 | A cohort study of cystic fibrosis and malignancy |
| Q93025301 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases |
| Q43072092 | A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk |
| Q28943455 | A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) |
| Q36682471 | A genome-wide association study of early menopause and the combined impact of identified variants |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q33821207 | A nested case-control study of fatal work related injuries among Brazilian steel workers |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q37524853 | A novel approach to exploring potential interactions among single-nucleotide polymorphisms of inflammation genes in gliomagenesis: an exploratory case-only study |
| Q36623882 | A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use |
| Q37131554 | A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes |
| Q39501944 | A population-based study of cancer risk in twins: relationships to birth order and sexes of the twin pair |
| Q39067219 | A study of risk factors for acquisition of Epstein-Barr virus and its subtypes |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q57026072 | Abstract 854: Ovarian cancer risk factors by histologic subtypes: evidence for etiologic heterogeneity |
| Q57319547 | Abstract P3-08-04: Impact of CYP3A variation on estrone levels and breast cancer risk |
| Q89506041 | Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q34655215 | Allergic conditions and brain tumor risk |
| Q48185601 | Allergy and glioma risk: test of association by genotype. |
| Q34623991 | Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial |
| Q34304171 | An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype |
| Q31125970 | An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q48235089 | An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors |
| Q43412423 | An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk |
| Q58496181 | Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. |
| Q47348964 | Analysis of immune activation and clinical events in acute infectious mononucleosis |
| Q37683663 | Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results |
| Q50658414 | Anthropometric factors and risk of melanoma in women: a pooled analysis. |
| Q64056497 | Association analyses identify 31 new risk loci for colorectal cancer susceptibility |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q56089359 | Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q56337548 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q61124964 | Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia |
| Q60917552 | Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
| Q60912720 | Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
| Q59830539 | Author's Response: Response to commentary: Meningioma and mobile phone use--a collaborative case-control study in five North European countries |
| Q62583537 | BENIGN NAEVI ASSOCIATED WITH HIGH RISK OF MELANOMA |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q34286504 | Benign melanocytic naevi as a risk factor for malignant melanoma |
| Q39110546 | Bias caused by migration in case-control studies of prenatal risk factors for childhood and adult diseases |
| Q39110533 | Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths |
| Q34561099 | Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis |
| Q39463045 | Birthweight and other pregnancy outcomes in a cohort of women with pre-gestational insulin-treated diabetes mellitus, Scotland, 1979-95. |
| Q36642272 | Birthweight, childhood growth and risk of breast cancer in a British cohort |
| Q43581448 | Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study |
| Q62583499 | Breast Cancer Risk After Recent Childbirth |
| Q47576468 | Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study |
| Q36924721 | Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors |
| Q62583508 | Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study |
| Q64074174 | Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q46088775 | Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI. |
| Q57319691 | CASP8 D302H and meningioma risk: An analysis of five case-control series |
| Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
| Q44288178 | CYP3A variation, premenopausal estrone levels, and breast cancer risk |
| Q38967213 | Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study |
| Q62583530 | Cancer in Italian migrant populations. England and Wales: incidence |
| Q57241693 | Cancer in Italian migrant populations. England and Wales: mortality |
| Q45185496 | Cancer in laboratory workers |
| Q34560206 | Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study |
| Q36615940 | Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study |
| Q38977631 | Cancer incidence following treatment for infertility at a clinic in the UK. |
| Q36081907 | Cancer incidence in England and Wales and New Zealand and in migrants between the two countries |
| Q36643935 | Cancer incidence in the Falkland Islands |
| Q28269115 | Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study |
| Q35994563 | Cancer mortality in African and Caribbean migrants to England and Wales. |
| Q36081376 | Cancer mortality in Indian and British ethnic immigrants from the Indian subcontinent to England and Wales |
| Q47648609 | Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys |
| Q47648595 | Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys |
| Q33583584 | Cancer of the testis, socioeconomic status, and occupation |
| Q36740675 | Cancer risk in patients with constitutional chromosome deletions: a nationwide British cohort study |
| Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
| Q62583523 | Carcinoma in situ in boys with cryptorchidism: when can it be detected? |
| Q33687201 | Changes in diet and coronary heart disease mortality among social classes in Great Britain |
| Q50999553 | Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. |
| Q37630918 | Childhood body size and pubertal timing in relation to adult mammographic density phenotype |
| Q28943530 | Chromosome 7p11.2 (EGFR) variation influences glioma risk |
| Q56089366 | Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts |
| Q48283361 | Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts |
| Q62583525 | Cohorts of Insulin-treated Patients with Diabetes |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q37681743 | Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study |
| Q34399372 | Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q98390794 | Common susceptibility loci for male breast cancer |
| Q28943376 | Common variation at 10p12.31 near MLLT10 influences meningioma risk |
| Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
| Q62583503 | Comparative validation of breast cancer risk prediction models and projections for future risk stratification |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q35994158 | Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales |
| Q35975722 | Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation |
| Q57319766 | Comprehensive Analysis of DNA Repair Gene Variants and Risk of Meningioma |
| Q55467579 | Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. |
| Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
| Q89662330 | Correction to: Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q48191778 | Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone |
| Q101216461 | Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers |
| Q34604460 | Current knowledge and future research directions in treatment-related second primary malignancies |
| Q97548420 | DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study |
| Q37685729 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause |
| Q91214942 | Data must be shared-also with researchers outside of Europe |
| Q36839027 | Deciphering the 8q24.21 association for glioma |
| Q36177633 | Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone |
| Q34132265 | Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment |
| Q24633288 | Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study |
| Q30899396 | Development and validation of a melanoma risk score based on pooled data from 16 case-control studies |
| Q39501914 | Do tanning lamps cause melanoma? An epidemiologic assessment |
| Q36615916 | Does growth hormone therapy increase the risk of cancer? |
| Q47642032 | Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study |
| Q55110745 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
| Q62583512 | Effect of Delays in Processing Blood Samples on Measured Endogenous Plasma Sex Hormone Levels in Women |
| Q40135577 | Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women |
| Q37592886 | Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study |
| Q38026503 | Effectiveness of primary prevention of occupational exposures on cancer risk |
| Q41641176 | Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause |
| Q36245425 | Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries |
| Q34991832 | Epidemiologic evidence on mobile phones and tumor risk: a review |
| Q35122830 | Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma |
| Q46232424 | Epidemiology of Radiofrequency Exposure: Ahlbom et al. Respond |
| Q39355032 | Epidemiology of eye cancer in adults in England and Wales, 1962-1977. |
| Q24811012 | Epidemiology of health effects of radiofrequency exposure |
| Q93602012 | Epidemiology of malignant melanoma |
| Q38709912 | Epidemiology of melanocytic nevi |
| Q36047428 | Epidemiology of melanoma of the eye in the Oxford Region, 1952-78. |
| Q64078095 | Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk |
| Q35914867 | Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis |
| Q51766497 | Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. |
| Q44087148 | Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q39544580 | Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma |
| Q62583502 | Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q57319538 | FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma |
| Q42596418 | Familial concordance for age at menarche: analyses from the Breakthrough Generations Study |
| Q42598119 | Familial concordance for age at natural menopause: results from the Breakthrough Generations Study |
| Q44611248 | Familial concordance for height and its components: analyses from the Breakthrough Generations Study |
| Q38746332 | Family history and risk of breast cancer: an analysis accounting for family structure |
| Q36135438 | Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
| Q42881651 | Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q46593237 | Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q26777290 | GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults |
| Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
| Q62583319 | Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk |
| Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q62583135 | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma |
| Q34031201 | Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q48345170 | Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q56375615 | Genome-wide association analysis identifies a meningioma risk locus at 11p15.5 |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q29248527 | Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q93270780 | Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q29417050 | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk |
| Q29614921 | Genome-wide association study identifies five susceptibility loci for glioma |
| Q36145972 | Genome-wide association study identifies multiple susceptibility loci for glioma |
| Q52720511 | Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. |
| Q59795648 | Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma |
| Q61847493 | Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan |
| Q47125417 | Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q23919638 | Genome-wide association study of glioma and meta-analysis |
| Q38873936 | Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors |
| Q36099366 | Genome-wide homozygosity signature and risk of Hodgkin lymphoma |
| Q36019187 | Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma |
| Q35984369 | Geographic distribution of lung and stomach cancers in England and Wales over 50 years: changing and unchanging patterns |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q49125344 | Growth hormone treatment of children with brain tumors and risk of tumor recurrence. |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q37121271 | High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium |
| Q34593492 | History of allergic disease and risk of meningioma |
| Q40475089 | History of allergies and risk of glioma in adults. |
| Q62583526 | How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? |
| Q51925106 | IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma. |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q58743933 | Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q23924183 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 |
| Q62583539 | Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine |
| Q38976823 | Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q48373001 | Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease |
| Q52659457 | Influence of obesity-related risk factors in the aetiology of glioma. |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q28383820 | Inherited variation in immune genes and pathways and glioblastoma risk |
| Q40358881 | Interaction between 5 genetic variants and allergy in glioma risk |
| Q41204372 | International trends in cutaneous melanoma |
| Q36064720 | Interpretation of England and Wales cancer mortality data: the effect of enquiries to certifiers for further information |
| Q53182487 | Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q35185070 | Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners came from United States or Africa? |
| Q62583522 | Is the apparent rise in cancer mortality in the elderly real? analysis of changes in certification and coding of cause of death in England and Wales, 1970–1990 |
| Q53901004 | Is the incidence of testis cancer related to trauma or temperature? |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q35994647 | Kaposi's sarcoma in England and Wales before the AIDS epidemic |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q37265393 | Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause |
| Q36671696 | Life-course body size and perimenopausal mammographic parenchymal patterns in the MRC 1946 British birth cohort |
| Q55463059 | Location of gliomas in relation to mobile telephone use: a case-case and case-specular analysis. |
| Q97686574 | Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study |
| Q62583519 | Long-term survival in Hodgkin's disease patients |
| Q36896094 | Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. |
| Q43543604 | Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment |
| Q45920724 | MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. |
| Q28395267 | Male breast cancer, age and sex chromosome aneuploidy |
| Q62583520 | Maternal and child constitutional factors and the frequency of melanocytic naevi in children |
| Q56978973 | Maternal breast cancer risk in relation to birthweight and gestation of her offspring |
| Q39091615 | Maternal mortality in England and Wales 1970-1985: an analysis by country of birth |
| Q59830689 | Medical history, cigarette smoking and risk of acoustic neuroma: An international case-control study |
| Q39668629 | Melanocytic naevi and melanoma: an epidemiological perspective |
| Q43682507 | Melanocytic nevus counts and melanoma |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q39855662 | Meningioma and mobile phone use--a collaborative case-control study in five North European countries |
| Q37203133 | Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? |
| Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q39006395 | Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer |
| Q24651126 | Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries |
| Q34574151 | Mobile phone use and risk of glioma in 5 North European countries |
| Q30500761 | Mobile phone use and risk of glioma in adults: case-control study |
| Q30471612 | Mobile phones, brain tumors, and the interphone study: where are we now? |
| Q62583517 | Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes |
| Q38976807 | Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal |
| Q90391710 | Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study |
| Q62583533 | Mortality and Cancer Incidence in Vietnamese Refugees in England and Wales: A Follow-Up Study |
| Q62583498 | Mortality and cancer incidence in carriers of constitutional t(11;22)(q23;q11) translocations: A prospective study |
| Q59291498 | Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study |
| Q62583527 | Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study |
| Q47619340 | Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings |
| Q33953207 | Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study |
| Q47731327 | Mortality and cancer incidence in women with extra X chromosomes: a cohort study in Britain |
| Q38505882 | Mortality during 25 years of follow-up of a cohort with diabetes |
| Q62583515 | Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes |
| Q33819859 | Mortality from injuries and other causes in a cohort of 21,800 Brazilian steel workers |
| Q59291467 | Mortality in Women with Turner Syndrome in Great Britain: A National Cohort Study |
| Q34456794 | Mortality in patients with Klinefelter syndrome in Britain: a cohort study |
| Q38501730 | Mortality in patients with congenital adrenal hyperplasia: a cohort study |
| Q38976827 | Mortality in the Portuguese thorotrast study |
| Q33818379 | Mortality in uranium miners in west Bohemia: a long-term cohort study |
| Q45192733 | Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort study |
| Q33820682 | Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants |
| Q59291487 | Mortality risks in patients with constitutional autosomal chromosome deletions in Britain: a cohort study |
| Q57202062 | Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3 |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q61868132 | Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study |
| Q51016502 | Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. |
| Q37311513 | Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis |
| Q92356825 | Night shift work and risk of breast cancer in women: the Generations Study cohort |
| Q44985994 | No Evidence for BRAF as a melanoma/nevus susceptibility gene |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q35492571 | Non-fatal work related injuries in a cohort of Brazilian steelworkers. |
| Q39006292 | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study |
| Q30614555 | Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden |
| Q33573242 | Occupational associations of testicular cancer in south east England |
| Q37234793 | Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium |
| Q36610065 | Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study |
| Q35984286 | Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer |
| Q39463033 | Overseas sun exposure, nevus counts, and premature skin aging in young English women: a population-based survey |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q34785426 | Part-time medical training: 15 years' experience in the Oxford region |
| Q62583524 | Patterns of Lung Cancer Mortality among Uranium Miners in West Bohemia with Varying Rates of Exposure to Radon and Its Progeny |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q37555606 | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
| Q39110538 | Pre-natal and early life risk factors for childhood onset diabetes mellitus: a record linkage study |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q38494337 | Predictors of first nonfatal occupational injury following employment in a Brazilian steelworks |
| Q50743068 | Pregnancy history and incidence of melanoma in women: a pooled analysis. |
| Q36028072 | Prenatal and familial associations of testicular cancer |
| Q33687493 | Prenatal factors in the aetiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953-73. |
| Q39110530 | Prenatal risk factors for cryptorchidism: a record linkage study |
| Q37350137 | Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups |
| Q37096858 | Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom |
| Q51928598 | Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes. |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q38199206 | Radiologic features of breast cancer after mantle radiation therapy for Hodgkin disease: a study of 230 cases |
| Q62583529 | Radon exposure and cancers other than lung cancer among uranium miners in West Bohemia |
| Q43659618 | Recent trends in diabetes mortality in England and Wales |
| Q36081514 | Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use |
| Q34068137 | Relation between phenotype and banal melanocytic naevi |
| Q62583506 | Reply to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study" |
| Q93106902 | Reply to Comment on: "Night shift work and risk of breast cancer in women: the Generations Study cohort" |
| Q62583521 | Reply to the letter from Rettig and Lemon |
| Q45960581 | Reply: Mobile phone use and acoustic neuroma in five North European countries. |
| Q59291360 | Reproducibility of Estradiol and Testosterone Levels in Postmenopausal Women Over 5 Years: Results From the Breakthrough Generations Study |
| Q48888372 | Reproductive factors and risk of meningioma and glioma. |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q57452824 | Response to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study" |
| Q62583500 | Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study” |
| Q53176639 | Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy. |
| Q24814870 | Review of the epidemiologic literature on EMF and Health |
| Q62583518 | Risk Factors for Breast Cancer at Young Ages in Twins: An International Population-Based Study |
| Q62583531 | Risk factors for melanoma: site variation in minimal erythema dose |
| Q40390297 | Risk factors for pituitary tumors: a case-control study |
| Q36620219 | Risk factors for testicular cancer: a case-control study in twins. |
| Q62583504 | Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort |
| Q62583513 | Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study |
| Q34141753 | Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study |
| Q37225705 | Risk of cervical abnormality after age 50 in women with previously negative smears |
| Q39110542 | Risk of congenital inguinal hernia in siblings: a record linkage study |
| Q58283406 | Risk of cutaneous melanoma associated with a family history of the disease |
| Q34058310 | Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). |
| Q36135287 | Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study |
| Q38894439 | Risk of death from motor-vehicle injury in Brazilian steelworkers: a nested case-control study. |
| Q39501892 | Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus |
| Q62583516 | Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching1 |
| Q56828474 | Risk of ocular melanoma in relation to cutaneous and IRIS naevi |
| Q39877308 | Risk of pituitary tumors in cellular phone users: a case-control study |
| Q39142600 | Risk of premature menopause after treatment for Hodgkin's lymphoma. |
| Q39501899 | Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment |
| Q35977925 | Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy |
| Q35821634 | Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation |
| Q36244606 | Risk of testicular cancer in cohort of boys with cryptorchidism |
| Q39501927 | Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. |
| Q62583505 | Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation |
| Q39501956 | Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. |
| Q28606408 | Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis |
| Q36622584 | Season of birth and diagnosis of children with leukaemia: an analysis of over 15 000 UK cases occurring from 1953-95. |
| Q33686047 | Seasonal variations in cryptorchidism |
| Q35992751 | Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford Region |
| Q44464364 | Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study |
| Q36419982 | Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital |
| Q35634560 | Second primary breast cancer after Hodgkin's disease |
| Q59291440 | Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study |
| Q38976838 | Sex differences in the risks of hormone-dependent cancers |
| Q36134571 | Sex differences in time trends of colorectal cancer in England and Wales: the possible effect of female hormonal factors |
| Q47870125 | Sex ratio in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. |
| Q45731201 | Sexual history and Epstein-Barr virus infection |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q91214939 | Sharing data safely while preserving privacy |
| Q62583535 | Site-specific melanocytic naevus counts as predictors of whole body naevi |
| Q47162371 | Smoking and risk of breast cancer in the Generations Study cohort |
| Q42460617 | Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi |
| Q37209909 | Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls |
| Q45762676 | Sunlamps and the risk of melanoma: Authors' reply. |
| Q93540711 | Sunshine and malignant melanoma |
| Q45292213 | Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study |
| Q44903190 | Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study |
| Q24564780 | Testicular cancer and antecedent diseases |
| Q62583534 | Testis cancer: Post-natal hormonal factors, sexual behaviour and fertility |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q35263089 | The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology |
| Q39157296 | The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus |
| Q33866752 | The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q23912478 | The INTERPHONE study: design, epidemiological methods, and description of the study population |
| Q28396298 | The Intracranial Distribution of Gliomas in Relation to Exposure From Mobile Phones: Analyses From the INTERPHONE Study |
| Q57025274 | The National Cancer Institute Cohort Consortium: an international pooling collaboration of 58 cohorts from 20 countries |
| Q38370371 | The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium |
| Q92608759 | The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3) |
| Q36295134 | The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia |
| Q55466741 | The common D302H variant of CASP8 is associated with risk of glioma. |
| Q36080194 | The epidemiology of carcinoid tumours in England and Scotland |
| Q39501980 | The epidemiology of testicular cancer |
| Q93054131 | The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis |
| Q62583514 | The immune response to primary EBV infection: a role for natural killer cells |
| Q43939603 | The prevalence and characteristics of congenital pigmented lesions in newborn babies in Oxford |
| Q42213216 | The relationship between obesity and exposure to light at night: cross-sectional analyses of over 100,000 women in the Breakthrough Generations Study |
| Q52858723 | The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. |
| Q62583536 | The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients |
| Q38509179 | The risk of melanoma in patients with congenital nevi: a cohort study |
| Q40003698 | The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme |
| Q33686654 | The value of England and Wales congenital malformation notification scheme data for epidemiology: male genital tract malformations |
| Q35982679 | Thymus cancer epidemiology in England and Wales |
| Q35975776 | Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution |
| Q37690092 | Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study |
| Q35163531 | Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium |
| Q91311927 | Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q45730808 | Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells |
| Q36291580 | Trends in cancer incidence and mortality in Scotland: description and possible explanations. |
| Q41121211 | Trends in cancer mortality in 15 industrialized countries, 1969-1986. |
| Q43559084 | Twinning in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan. |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q30356919 | Ultrasound Tomography Evaluation of Breast Density: A Comparison With Noncontrast Magnetic Resonance Imaging. |
| Q28943378 | Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma |
| Q33483893 | Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data |
| Q62583538 | Women doctors in training: problems and progress |
| Q59291476 | XRCC1 and XRCC3 variants and risk of glioma and meningioma |
| Q122925830 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.